pindolol has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, PJ; Grandordy, BM; Page, CP; Rhoden, KJ; Robertson, DN | 1 |
| Kogo, H; Matsudaira, T; Satoh, T | 1 |
2 other study(ies) available for pindolol and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
The effect of platelet activating factor on pulmonary beta-adrenoceptors.
Topics: Animals; Guinea Pigs; Histamine; In Vitro Techniques; Iodocyanopindolol; Isoproterenol; Lung; Male; Pindolol; Platelet Activating Factor; Receptors, Adrenergic, beta; Trachea | 1987 |
A possible role of antihypertensive polar renomedullary lipid (APRL) and prostaglandin E2 in the kidney in the antihypertensive action of pindolol.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dinoprostone; Electrolytes; Indomethacin; Kidney; Male; Phospholipid Ethers; Pindolol; Platelet Activating Factor; Prostaglandins E; Rats; Rats, Inbred SHR; Thiazoles | 1985 |